Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials

A systematic review and meta-analysis was performed to assess the kidney and cardiovascular (CV) outcomes of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) stage 3b-4. We conducted a systematic review and meta-analy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes research and clinical practice 2021-10, Vol.180, p.109033-109033, Article 109033
Hauptverfasser:	Cao, Haiyan, Liu, Youxia, Tian, Zhixia, Lian, Yuhang, Jia, Junya, Liu, Ming, Li, Dong
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular outcomes CKD 3b-4 Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy Glucose Humans Kidney Kidney outcomes Meta-analysis Randomized Controlled Trials as Topic Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - drug therapy Renal Insufficiency, Chronic - epidemiology SGLT2 inhibitors Sodium Type 2 diabetes mellitus (T2DM)
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!